During the last session, Abeona Therapeutics Inc (NASDAQ:ABEO)’s traded shares were 1.1 million, with the beta value of the company hitting 1.61. At the end of the trading day, the stock’s price was $3.19, reflecting an intraday gain of 0.63% or $0.02. The 52-week high for the ABEO share is $9.01, that puts it down -182.45 from that peak though still a striking 11.29% gain since the share price plummeted to a 52-week low of $2.83. The company’s market capitalization is $87.28M, and the average trade volume was 485.96K shares over the past three months.
Abeona Therapeutics Inc (NASDAQ:ABEO) trade information
Abeona Therapeutics Inc (ABEO) registered a 0.63% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.63% in intraday trading to $3.19, hitting a weekly high. The stock’s 5-day price performance is -57.64%, and it has moved by -56.66% in 30 days. Based on these gigs, the overall price performance for the year is -2.15%.
Abeona Therapeutics Inc (ABEO) estimates and forecasts
Statistics show that Abeona Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Abeona Therapeutics Inc (ABEO) shares have gone down -20.25% during the last six months, with a year-to-date growth rate less than the industry average at 10.73% against 12.90. In the rating firms’ projections, revenue will decrease -80.90% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 250k as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 250k by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 38.92%. While earnings are projected to return 15.55% in 2024.
ABEO Dividends
Abeona Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
